Donepezil improves cognition in patients with vascular dementia: Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Roman, GC
Pratt, RD
Perdomo, CA
Perdomo, CA
机构：
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[2] Eisai Inc, Teaneck, NJ USA
来源：
NEUROBIOLOGY OF AGING | 2002年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
212
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [41] Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes A 24-week, randomized, double-blind, placebo-controlled trial
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES CARE, 2013, 36 (11) : 3396 - 3404
  • [42] Effect of inorganic nitrate on metabolic parameters in patients with type 2 diabetes: A 24-week randomized double-blind placebo-controlled clinical trial
    Bahadoran, Zahra
    Norouzirad, Reza
    Mirmiran, Parvin
    Gaeini, Zahra
    Jeddi, Sajad
    Shokri, Majid
    Azizi, Fereidoun
    Ghasemi, Asghar
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2021, 107 : 58 - 65
  • [43] Muraglitazar, a dual (α/γ) PPAR activator:: A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes
    Buse, JB
    Rubin, CJ
    Frederich, R
    Viraswami-Appanna, K
    Lin, KC
    Montoro, R
    Shockey, G
    Davidson, JA
    CLINICAL THERAPEUTICS, 2005, 27 (08) : 1181 - 1195
  • [44] A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Subbiah, P
    Whalen, E
    NEUROLOGY, 2001, 57 (04) : 613 - 620
  • [45] Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: A 12-week, randomized, double-blind, placebo-controlled trial
    Malhotra, AK
    Keefe, R
    Meltzer, H
    Kane, J
    Murthy, A
    Sovel, M
    Xu, YK
    Gold, L
    Goldman, R
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S171 - S171
  • [46] Donepezil for dementia in Parkinson's disease: A randomized, double-blind, placebo-controlled, crossover study.
    Ravina, B
    Putt, M
    Siderowf, A
    Farrar, JT
    Gillespie, M
    Crawley, A
    Fernandez, H
    Treischmann, M
    Reichwein, S
    Simuni, T
    MOVEMENT DISORDERS, 2004, 19 (09) : 1132 - 1133
  • [47] Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study
    Simpson, Richard W.
    Nicholson, Geoffrey C.
    Proietto, Joseph
    Sarah, Alana
    Sanders, Kerrie M.
    Phillips, Gabrielle
    Chambers, Jo
    MacGinley, Rob
    Orford, Neil
    Walder, Ken
    Krippner, Guy
    Skoff, Kathy
    Wacher, Vincent J.
    DIABETES CARE, 2014, 37 (11) : 3121 - 3123
  • [48] Efficacy and safety of donepezil in vascular dementia: results from the largest double-blind trial in vascular dementia patients
    Roman, G.
    Black, S.
    Royall, D. R.
    Surick, I.
    Kumar, D.
    Schindler, R.
    Posner, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S481 - S482
  • [49] Vitamin E does not reduce symptoms of rheumatoid arthritis: A 24-week randomized, double-blind, placebo-controlled study.
    Boileau, N
    Blumberg, J
    Dallal, GE
    Golly, I
    Roubenoff, R
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S179 - S179
  • [50] A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis
    Khanna, Dinesh
    Denton, Christopher P.
    Furst, Daniel E.
    Mayes, Maureen D.
    Matucci-Cerinic, Marco
    Smith, Vanessa
    de Vries, Dick
    Ford, Paul
    Bauer, Yasmina
    Randall, Matthew J.
    Ebrahimpoor, Mitra
    Kupcsik, Laszlo
    Stiers, Pieter-Jan
    Deberdt, Liesbeth
    Prasad, Niyati
    Lim, Sharlene
    Pujuguet, Philippe
    Ahmed, Sohail
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (08) : 1434 - 1444
12345